C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2009
11/12/2009	US20090281137 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2009	US20090281125 Heterocyclic Compounds Useful in Treating Diseases and Conditions
11/12/2009	US20090281117 1-{[2-(2,4-Difluorophenyl)-1-(3-ethoxyphenyl)-1H-imidazol-4-yl]carbonyl}-4-(2-naphthyl)piperazine, useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes
11/12/2009	US20090281116 Pyrrole derivatives, preparation thereof and therapeutic use thereof
11/12/2009	US20090281099 Substituted pyrazinone derivatives for use as a medicine
11/12/2009	US20090281094 Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof
11/12/2009	US20090281087 Compounds II
11/12/2009	US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009	US20090281069 Organic compounds
11/12/2009	CA2728893A1 Inhibitors of syk protein kinase
11/12/2009	CA2721303A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/11/2009	EP2116548A1 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
11/11/2009	EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
11/11/2009	EP2116539A1 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
11/11/2009	EP2116530A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents
11/11/2009	EP2116242A1 New pharmaceutical composition
11/11/2009	EP2114924A2 Co-crystals and pharmaceutical compositions comprising the same
11/11/2009	EP2114904A1 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same
11/11/2009	EP2114901A1 Hiv inhibiting 6-substituted pyrimidines
11/11/2009	EP2114900A1 Thiopyrimidine-based compounds and uses thereof
11/11/2009	EP2114895A1 Talarazole metabolites
11/11/2009	EP2114879A1 Ppar active compounds
11/11/2009	EP2114877A1 Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists
11/11/2009	EP2114454A2 Chemical linkers and cleavable substrates and conjugates thereof
11/11/2009	EP2007753B1 Heterocyclic gaba alpha subtype selective receptor modulators
11/11/2009	EP1917246B1 Benzoquinazoline derivatives and their use in treating bone disorders
11/11/2009	EP1884240B1 Pharmaceutical for prevention or treatment of bone metabolic disease
11/11/2009	EP1745021B1 Hydroformylation process for pharmaceutical intermediate
11/11/2009	EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009	EP1578731B1 Process for the preparation of pyrimidine compounds
11/11/2009	EP1492487B1 Mitotic kinesin inhibitors
11/11/2009	EP1477186B1 Antipruritics
11/11/2009	EP1427418B1 Piperazinone compounds as anti-tumor and anti-cancer agents
11/11/2009	EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009	CN101578273A Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
11/11/2009	CN101578265A Sulfonamide derivatives as chymase inhibitors
11/11/2009	CN101578262A Radiolabelling via fluorination of aziridines
11/11/2009	CN101578261A Heteroaryl-substituted serine amides
11/11/2009	CN101575330A Novel voriconazole broad-spectrum antifungal medicine compound, broad-spectrum antifungal medicine composition and application thereof
11/11/2009	CN101575320A Water-soluble triazole antifungal compound
11/11/2009	CN101575318A Novel dihydropyridine compound and application thereof on preparing drugs for curing and/or preventing virus diseases
11/11/2009	CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009	CN100558715C Protein kinase inhibitors
11/11/2009	CN100558713C Pyridazine derivatives and their use as therapeutic agents
11/11/2009	CN100558712C Therapeutic molecules and methods-1
11/11/2009	CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009	US7615646 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
11/10/2009	US7615642 Therapeutic compounds
11/10/2009	US7615635 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics
11/10/2009	US7615634 intermediate for synthesis an enzyme inhibitor of cyclin-dependent kinases, having antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors
11/10/2009	US7615633 Organic electroluminescent device and platinum compound
11/10/2009	US7615569 Inhibitors of ion channels
11/10/2009	US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009	US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009	US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents
11/10/2009	US7615555 Piperidine derivatives as modulators of chemokine receptor CCR5
11/10/2009	US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009	US7615552 Fused heterocyclic compounds
11/10/2009	US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009	CA2416785C Novel arylethene-sulfonamides
11/10/2009	CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/05/2009	WO2009134750A1 Benzoimidazoles as prolyl hydroxylase inhibitors
11/05/2009	WO2009134726A1 Substituted pyrimidine derivatives as histamine h4 receptor ligands
11/05/2009	WO2009133861A1 Cyclic amine compound
11/05/2009	WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009	WO2009133387A1 Indole- 3 -glyoxylamide derivatives for use as calcium ion channel modulators
11/05/2009	WO2009133170A1 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
11/05/2009	WO2009133070A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
11/05/2009	WO2009132774A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/05/2009	WO2009132739A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/05/2009	WO2009112954A3 Processes for the preparation of bosentan and related compounds
11/05/2009	WO2009034433A3 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
11/05/2009	US20090275750 Dipeptidyl peptidase inhibitors
11/05/2009	US20090275748 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
11/05/2009	US20090275607 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
11/05/2009	US20090275603 NF- kB Inhibitors And Uses Thereof
11/05/2009	US20090275591 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitor
11/05/2009	US20090275589 Pyridazine Compound and Use Thereof
11/05/2009	US20090275572 Fab i inhibitors
11/05/2009	US20090275569 Benzotriazine Inhibitors of Kinases
11/05/2009	US20090275561 Compounds for the Treatment of Hepatitis C
11/05/2009	US20090275141 Affinity Adsorbents for Factor VIII and Von Willebrand's Factor
11/05/2009	US20090275099 Methods and compositions for treating diseases and conditions associated with mitochondrial function
11/05/2009	US20090274656 Hepatitis c virus inhibitors
11/05/2009	US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009	US20090273277 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/05/2009	CA2723209A1 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
11/05/2009	CA2722813A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/05/2009	CA2722772A1 Benzoimidazoles as prolyl hydroxylase inhibitors
11/05/2009	CA2722131A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
11/04/2009	EP2113503A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/04/2009	EP1720868B1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/04/2009	EP1446387B1 Substituted aryl 1,4-pyrazine derivatives
11/04/2009	EP1366040B1 Amorphous form of cell cycle inhibitor
11/04/2009	EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009	CN101573343A HIV inhibiting 6-substituted pyrimidines
11/04/2009	CN101573339A Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
11/04/2009	CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/03/2009	US7612201 Pyrazole compounds
11/03/2009	US7612099 Such as 3-[(5-Fluoro-3-methyl-1H-indol-2-yl)-phenyl-methyl]-4-hydroxy-5-isopropyl-1,5-dihydro-pyrrol-2-one which inhibits chymase

1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 626